- Home
- LONA vs NAMM Comparison
LONA vs NAMM Comparison
Compare LONA & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LONA | NAMM |
|---|---|---|
| Founded | 2011 | 2024 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 73.6M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | LONA | NAMM |
|---|---|---|
| Price | $6.95 | $1.30 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 40.2K | ★ 446.4K |
| Earning Date | 05-08-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $76.84 |
| Revenue Next Year | N/A | $85.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.21 | $0.91 |
| 52 Week High | $14.21 | $7.42 |
Technical Indicators
Market Signals| Indicator | LONA | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 38.12 |
| Support Level | $6.86 | $0.94 |
| Resistance Level | $8.57 | $1.69 |
| Average True Range (ATR) | 0.58 | 0.08 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 29.70 | 12.87 |
Price Performance
Historical ComparisonAbout LONA LeonaBio Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
About NAMM Namib Minerals Ordinary Shares
Namib Minerals is a Pan-African multi-asset mining platform for precious and critical metals, particularly gold. The company is an established gold producer with an attractive portfolio of three gold mines in Zimbabwe, Africa. Its gold mines include How Mine, Mazowe Mine, and Redwing Mine. Its segments include the How Mine, the Mazowe Mine, and the Redwing Mine, and Others.